Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Autoimmune Pancreatitis | Research article

Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients

Authors: Xiang-Peng Zeng, Ting-Ting Liu, Lu Hao, Lei Xin, Teng Wang, Lin He, Jun Pan, Dan Wang, Ya-Wei Bi, Jun-Tao Ji, Zhuan Liao, Ting-Ting Du, Jin-Huan Lin, Di Zhang, Hong-Lei Guo, Hui Chen, Wen-Bin Zou, Bai-Rong Li, Zhi-Jie Cong, Li-Sheng Wang, Zheng-Lei Xu, Ting Xie, Ming-Hao Liu, An-Mei Deng, Zhao-Shen Li, Liang-Hao Hu

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Autoimmune factor was regarded as one of the risk factors in the pathogenesis of chronic pancreatitis (CP), especially for autoimmune pancreatitis (AIP). However, whether autoimmune factor plays a role in non-AIP CP or not was unknown.

Methods

Hospitalized patients with non-AIP CP from January 2010 to October 2016 were detected for 22 autoantibodies at the time of hospital admission. Autoantibodies with frequency > 0.5% were enrolled to calculate the frequency in historial healthy controls through literature search in PubMed. Differentially expressed autoantibodies were determined between patients and historial healthy controls, and related factors were identified by multivariate logistic regression analysis.

Results

In a total of 557 patients, 113 cases were detected with 19 kinds of positive autoantibodies, among them anti-β2-glycoprotein I (β2-GPI) antibody was most frequent (9.16%). Compared with historial healthy controls, the frequencies of serum β2-GPI and anti SS-B antibody in patients were significantly higher, while frequencies of anti-smooth muscle antibody and anticardiolipin antibody were significantly lower (all P < 0.05). Multivariate logistic regression analysis result showed that diabetes mellitus (OR = 2.515) and common bile duct stricture (OR = 2.844) were the risk factors of positive β2-GPI antibody in patients while diabetes mellitus in first−/second−/third-degree relatives (OR = 0.266) was the protective factor. There were no related factors for other three differentially expressed autoantibodies.

Conclusions

Four autoantibodies were expressed differentially between patients with non-AIP CP and historial healthy controls. Due to limited significance for diagnosis and treatment of chronic pancreatitis, autoantibodies detection is not recommended conventionally unless suspected of AIP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nagar N, Dubale N, Jagadeesh R, Nag P, Reddy ND, Rao G. Unusual locations of pseudo aneurysms as a sequel of chronic pancreatitis. J Intervent Gastroenterol. 2011;1(1):28–32.CrossRef Nagar N, Dubale N, Jagadeesh R, Nag P, Reddy ND, Rao G. Unusual locations of pseudo aneurysms as a sequel of chronic pancreatitis. J Intervent Gastroenterol. 2011;1(1):28–32.CrossRef
2.
go back to reference Hao L, Wang T, He L, Bi YW, Zhang D, Zeng XP, et al. Risk factor for steatorrhea in pediatric chronic pancreatitis patients. BMC Gastroenterol. 2018;18(1):182.CrossRef Hao L, Wang T, He L, Bi YW, Zhang D, Zeng XP, et al. Risk factor for steatorrhea in pediatric chronic pancreatitis patients. BMC Gastroenterol. 2018;18(1):182.CrossRef
3.
go back to reference Zeng XP, Zhu XY, Li BR, Pan CS, Hao L, Pan J, et al. Spatial distribution of pancreatic stones in chronic pancreatitis. Pancreas. 2018;47(7):864–70.CrossRef Zeng XP, Zhu XY, Li BR, Pan CS, Hao L, Pan J, et al. Spatial distribution of pancreatic stones in chronic pancreatitis. Pancreas. 2018;47(7):864–70.CrossRef
4.
go back to reference Hao L, Zeng XP, Xin L, Wang D, Pan J, Bi YW, et al. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: a cohort of 1656 patients. Dig Liver Dis. 2017;49(11):1249–56.CrossRef Hao L, Zeng XP, Xin L, Wang D, Pan J, Bi YW, et al. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: a cohort of 1656 patients. Dig Liver Dis. 2017;49(11):1249–56.CrossRef
5.
go back to reference Wang D, Bi YW, Ji JT, Xin L, Pan J, Liao Z, et al. Extracorporeal shock wave lithotripsy is safe and effective for pediatric patients with chronic pancreatitis. Endoscopy. 2017;49(5):447–55.CrossRef Wang D, Bi YW, Ji JT, Xin L, Pan J, Liao Z, et al. Extracorporeal shock wave lithotripsy is safe and effective for pediatric patients with chronic pancreatitis. Endoscopy. 2017;49(5):447–55.CrossRef
6.
go back to reference Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.CrossRef Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.CrossRef
7.
go back to reference Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41(7):626–31.CrossRef Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41(7):626–31.CrossRef
8.
go back to reference Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12(16):2487–96.CrossRef Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12(16):2487–96.CrossRef
9.
go back to reference Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43(6):403–8.CrossRef Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43(6):403–8.CrossRef
10.
go back to reference Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016;51(2):85–92.CrossRef Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016;51(2):85–92.CrossRef
11.
go back to reference Lohr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, et al. United European gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153–99.CrossRef Lohr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, et al. United European gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153–99.CrossRef
12.
go back to reference Lohr JM, Faissner R, Koczan D, Bewerunge P, Bassi C, Brors B, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol. 2010;105(9):2060–71.CrossRef Lohr JM, Faissner R, Koczan D, Bewerunge P, Bassi C, Brors B, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol. 2010;105(9):2060–71.CrossRef
13.
go back to reference Hao M, Li W, Yi L, Yu S, Fan G, Lu T, et al. Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer. Sci Rep. 2016;6:27415.CrossRef Hao M, Li W, Yi L, Yu S, Fan G, Lu T, et al. Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer. Sci Rep. 2016;6:27415.CrossRef
14.
go back to reference Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;361(22):2135–42.CrossRef Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;361(22):2135–42.CrossRef
15.
go back to reference Tandon RK, Sato N, Garg PK, Consensus Study G. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol. 2002;17(4):508–18.CrossRef Tandon RK, Sato N, Garg PK, Consensus Study G. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol. 2002;17(4):508–18.CrossRef
16.
go back to reference Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2(3):252–61.CrossRef Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2(3):252–61.CrossRef
17.
go back to reference Wang W, Guo Y, Liao Z, Zou DW, Jin ZD, Zou DJ, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas. 2011;40(2):206–12.CrossRef Wang W, Guo Y, Liao Z, Zou DW, Jin ZD, Zou DJ, et al. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas. 2011;40(2):206–12.CrossRef
18.
go back to reference Lu WF. ERCP and CT diagnosis of pancreas divisum and its relation to etiology of chronic pancreatitis. World J Gastroenterol. 1998;4(2):150–2.CrossRef Lu WF. ERCP and CT diagnosis of pancreas divisum and its relation to etiology of chronic pancreatitis. World J Gastroenterol. 1998;4(2):150–2.CrossRef
19.
go back to reference Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36(1):54–62.CrossRef Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36(1):54–62.CrossRef
20.
go back to reference Bradley EL 3rd. Chronic obstructive pancreatitis as a delayed complication of pancreatic trauma. HPB Surg. 1991;5(1):49–59 discussion −60.CrossRef Bradley EL 3rd. Chronic obstructive pancreatitis as a delayed complication of pancreatic trauma. HPB Surg. 1991;5(1):49–59 discussion −60.CrossRef
21.
go back to reference Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol. 1992;148(12):3885–91.PubMed Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol. 1992;148(12):3885–91.PubMed
22.
go back to reference Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus. 2005;14(9):736–41.CrossRef Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus. 2005;14(9):736–41.CrossRef
23.
go back to reference Wang C, Niu DM, Hu J, Guan XC, Yang W, Wang JJ, et al. Elevated serum beta2-glycoprotein-I-lipoprotein(a) complexes levels are associated with the presence and complications in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2013;100(2):250–6.CrossRef Wang C, Niu DM, Hu J, Guan XC, Yang W, Wang JJ, et al. Elevated serum beta2-glycoprotein-I-lipoprotein(a) complexes levels are associated with the presence and complications in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2013;100(2):250–6.CrossRef
24.
go back to reference Cojocaru IM, Cojocaru M, Popescu AN, Popescu L, Tanasescu R. Study of antiphospholipid antibodies in type 2 diabetes mellitus with and without diabetic retinopathy. Rom J Intern Med. 2009;47(3):267–71.PubMed Cojocaru IM, Cojocaru M, Popescu AN, Popescu L, Tanasescu R. Study of antiphospholipid antibodies in type 2 diabetes mellitus with and without diabetic retinopathy. Rom J Intern Med. 2009;47(3):267–71.PubMed
25.
go back to reference Tarkun I, Hacihanefioglu A, Tarkun P, Cetinarslan B, Canturk Z. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2005;68(3):181–7.CrossRef Tarkun I, Hacihanefioglu A, Tarkun P, Cetinarslan B, Canturk Z. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2005;68(3):181–7.CrossRef
26.
go back to reference Xin L, Gao J, Wang D, Lin JH, Liao Z, Ji JT, et al. Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis. Sci Rep. 2017;7:40019.CrossRef Xin L, Gao J, Wang D, Lin JH, Liao Z, Ji JT, et al. Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis. Sci Rep. 2017;7:40019.CrossRef
27.
go back to reference Ghassem-Zadeh S, Gaida MM, Szanyi S, Acha-Orbea H, Frossard JL, Hinz U, et al. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis and pancreatic ductal adenocarcinoma. J Transl Med. 2017;15(1):126.CrossRef Ghassem-Zadeh S, Gaida MM, Szanyi S, Acha-Orbea H, Frossard JL, Hinz U, et al. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis and pancreatic ductal adenocarcinoma. J Transl Med. 2017;15(1):126.CrossRef
28.
go back to reference Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013;62(9):1373–80.CrossRef Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013;62(9):1373–80.CrossRef
29.
go back to reference Xin L, He YX, Zhu XF, Zhang QH, Hu LH, Zou DW, et al. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. Hepatobiliary Pancreat Dis Int. 2014;13(6):642–8.CrossRef Xin L, He YX, Zhu XF, Zhang QH, Hu LH, Zou DW, et al. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. Hepatobiliary Pancreat Dis Int. 2014;13(6):642–8.CrossRef
Metadata
Title
Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients
Authors
Xiang-Peng Zeng
Ting-Ting Liu
Lu Hao
Lei Xin
Teng Wang
Lin He
Jun Pan
Dan Wang
Ya-Wei Bi
Jun-Tao Ji
Zhuan Liao
Ting-Ting Du
Jin-Huan Lin
Di Zhang
Hong-Lei Guo
Hui Chen
Wen-Bin Zou
Bai-Rong Li
Zhi-Jie Cong
Li-Sheng Wang
Zheng-Lei Xu
Ting Xie
Ming-Hao Liu
An-Mei Deng
Zhao-Shen Li
Liang-Hao Hu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-0947-7

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.